首页>投融资

Grey Wolf Therapeutics

B轮

Grey Wolf Therapeutics Limited operates as a biotechnology company. The Company focused on immuno-oncology therapies and drugs.In January 2023, Grey Wolf Therapeutics announced the closing of an oversubscribed $49 million Series B financing co-led by Pfizer Ventures and Earlybird Venture Capital.In February 2019, Grey Wolf had completed a EUR10 million ($14 million) series A financing round

http://www.greywolftherapeutics.com/

470210

基本信息

公司全称

Grey Wolf Therapeutics
类型

新型免疫肿瘤药物开发商
产业领域

医药研发/制造、化学&生物药
公司人数

15人以下
地址

57 Woodstock Road OXFORD OXFORDSHIRE OX2; GB; Telephone: +441235644970;
联系电话

+44 1865 292038
邮箱

enquiries@gwt.bio
成立时间

2017-01-01

投融资

2024-05-23

B轮

5000万美元

Pfizer Ventures

Earlybird

ICG

Canaan Partners

British Patient Capital

Oxford Science Enterprises

Andera Partners
2024-05-23

B轮

5000万美元

ICG

辉瑞

Andera Partners

Canaan Partners

Earlybird Venture Capital

Oxford Science Enterprises

British Patient Capital
2023-01-26

B轮

4900万美元

Pfizer Ventures

Earlybird

Canaan Partners

British Patient Capital

Oxford Science Enterprises

Andera Partners
2023-01-26

B轮

4900万美元

Pfizer Ventures

Canaan Partners

British Patient Capital

Earlybird Venture Capital

Oxford Science Enterprises

Andera Partners
2023-01-26

B轮

4900万美元

辉瑞

Canaan Partners

Earlybird Venture Capital

Andera Partners

British Patient Capital

Oxford Science Enterprises
2020-01-09

A轮

330万美元

Canaan Partners

Andera Partners
2020-01-09

A轮

330万美元

Canaan Partners

Andera Partners
2019-02-11

A轮

1000万英镑

Canaan Partners

Andera Partners
2019-02-11

A轮

1000万英镑

Canaan Partners

Andera Partners
2018-04-01

A轮

500万英镑

未透露
2018-04-01

A轮

500万英镑

未透露
加载更多

Grey Wolf Therapeutics

基本信息

投融资

相关投融资企业